Paracetamol versus ibuprofen as required for fever or pain in the first year of life and the risk of eczema and bronchiolitis at age 1 year in New Zealand (PIPPA Tamariki): a multicentre, open-label, parallel-group, superiority, randomised controlled trial.

Tan E, McKinlay CJD, Riley J, Rao M, Mravicich L, Lawrence S, Eathorne A, Braithwaite I, Semprini A, Okesene-Gafa K, Sheridan N, Hoare K, Grant C, Johnson D, Weatherall M, Beasley R, Dalziel SR

Open source

DOI: 10.1016/s2352-4642(25)00341-4
Published: 2026 Mar
Container: The Lancet. Child & adolescent health
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-4642-25-00341-4,
  title = {Paracetamol versus ibuprofen as required for fever or pain in the first year of life and the risk of eczema and bronchiolitis at age 1 year in New Zealand (PIPPA Tamariki): a multicentre, open-label, parallel-group, superiority, randomised controlled trial.},
  author = {Tan E and McKinlay CJD and Riley J and Rao M and Mravicich L and Lawrence S and Eathorne A and Braithwaite I and Semprini A and Okesene-Gafa K and Sheridan N and Hoare K and Grant C and Johnson D and Weatherall M and Beasley R and Dalziel SR},
  year = {2026},
  journal = {The Lancet. Child \& adolescent health},
  doi = {10.1016/s2352-4642(25)00341-4},
  url = {https://doi.org/10.1016/s2352-4642(25)00341-4}
}

RIS

TY  - JOUR
TI  - Paracetamol versus ibuprofen as required for fever or pain in the first year of life and the risk of eczema and bronchiolitis at age 1 year in New Zealand (PIPPA Tamariki): a multicentre, open-label, parallel-group, superiority, randomised controlled trial.
AU  - Tan E
AU  - McKinlay CJD
AU  - Riley J
AU  - Rao M
AU  - Mravicich L
AU  - Lawrence S
AU  - Eathorne A
AU  - Braithwaite I
AU  - Semprini A
AU  - Okesene-Gafa K
AU  - Sheridan N
AU  - Hoare K
AU  - Grant C
AU  - Johnson D
AU  - Weatherall M
AU  - Beasley R
AU  - Dalziel SR
PY  - 2026
JO  - The Lancet. Child & adolescent health
DO  - 10.1016/s2352-4642(25)00341-4
UR  - https://doi.org/10.1016/s2352-4642(25)00341-4
ER  -

APA

E, T., CJD, M., J, R., M, R., L, M., S, L., A, E., I, B., A, S., K, O., N, S., K, H., C, G., D, J., M, W., R, B., & SR, D. (2026). Paracetamol versus ibuprofen as required for fever or pain in the first year of life and the risk of eczema and bronchiolitis at age 1 year in New Zealand (PIPPA Tamariki): a multicentre, open-label, parallel-group, superiority, randomised controlled trial.. The Lancet. Child & adolescent health. https://doi.org/10.1016/s2352-4642(25)00341-4

Source records

pubmed · retrieved 2026-09-27T09:28:50.584Z